Afuco™ Anti-NGF ADCC Therapeutic Antibody (Frunevetmab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to NGF. Frunevetmab is a Felinized monoclonal antibody that can be potentially used in the treatment of Feline osteoarthritis (OA). It inhibits the activity of nerve growth factor (NGF), a mediator of pain signaling and nerve growth.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-025ML |
| Pricing | Inquiry |
| Host | Feline |
| Target | NGF |
| Species Reactivity | Feline |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IHC, FC, IP, IF, Inhib |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |